537 related articles for article (PubMed ID: 18774757)
1. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
Anpalagan A; Condous G
J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
[TBL] [Abstract][Full Text] [Related]
2. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
4. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
5. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
6. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Al-Inany HG; Farquhar CM
Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E; Wildemeersch P
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
[TBL] [Abstract][Full Text] [Related]
9. Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland.
Backman T; Huhtala S; Tuominen J; Luoto R; Erkkola R; Blom T; Rauramo I; Koskenvuo M
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():23-6. PubMed ID: 11336430
[TBL] [Abstract][Full Text] [Related]
10. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
11. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Varma R; Sinha D; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):9-28. PubMed ID: 16325993
[TBL] [Abstract][Full Text] [Related]
12. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
Cameron IT
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():27-32. PubMed ID: 11336431
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
[TBL] [Abstract][Full Text] [Related]
14. Progestin-releasing intrauterine systems and leiomyoma.
Kaunitz AM
Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
[TBL] [Abstract][Full Text] [Related]
15. The levonorgestrel intrauterine system: more than a contraceptive.
Andersson K
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():15-22. PubMed ID: 11336429
[TBL] [Abstract][Full Text] [Related]
16. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
Lehtovirta P; Paavonen J; Heikinheimo O
Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
[TBL] [Abstract][Full Text] [Related]
17. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
[TBL] [Abstract][Full Text] [Related]
18. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
Wildemeersch D; Janssens D; Vrijens M; Weyers S
Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
[TBL] [Abstract][Full Text] [Related]
19. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
20. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
Yucel N; Baskent E; Karamustafaoglu Balci B; Goynumer G
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):560-563. PubMed ID: 29359457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
